CG Oncology, Inc. — Director's Dealing 2025

Apr 16, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CG Oncology, Inc. (CGON)
CIK: 0001991792
Period of Report: 2025-04-15

Reporting Person: Bellete Ambaw (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-15	Employee Stock Option (Right to Buy)	$20.11	A	284816	Acquired	2035-04-14	Common Stock (284816)	Direct

Footnotes

F1: 1/48th of the shares subject to the option vest monthly following April 15, 2025, the vesting commencement date, subject to the Report Person's continuous service to the Issuer through each vesting date.